Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines.

Source:http://linkedlifedata.com/resource/pubmed/id/11448899

Download in:

View as

General Info

PMID
11448899